Psoriasis patients undergoing biologic/other systemic therapies may experience mild SARS-CoV-2 infection A recent study published in the ‘Medicina’ Journal by the Multidisciplinary …
Featured Article
CXCL9: A biomarker for Vitiligo activity A recent study published in the ‘Nature’ scientific journal, proposed that the CXCL9 gene is a …
Rheumatoid Arthritis (RA) In a Global Burden of Disease (GBD) study conducted in the year 2010, which studied 291 conditions, Rheumatoid Arthritis …
The global prevalence rate of vitiligo ranges between 0.4%-3%, affecting individuals of all ages, races, and genders. Vitiligo treatment market dynamics Combination …
Inflammatory Bowel Diseases (IBD) currently affect approximately 0.5% of the Western world’s population. The globally occurring cases increased from 3.7 million to over …
The global prevalence of psoriasis ranges between 0.09% to 11.14 %. Psoriasis affects >120 million worldwide, with no cure till date. The …